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Although coronary artery spasm was considered to be a proved hypothesis more than a decade ago (l), its causes are still incompletely understood. We (2) have shown that ergonovine causes focal coronary artery spasm in patients with variant angina by a direct local coronary effect while producing only mild constriction on other segments of the spastic artery and adjacent branches. This local hyperreactivity in variant angina does not appear to be specific for a single type of agonist-receptor interaction, because spasm can be induced by a variety of stimuli acting through different receptors (3). It is not known, however, whether coronary spasm that occurs spontaneously also results from a local coronary hyperreactivity to a generalized constrictor stimulus affecting the coronary arteries diffusely or just from a localized stimulus generated at the site of the hyperreactive segment. To address this question we analyzed the behavior of spastic and nonspastic coronary artery segments during episodes of spontaneous coronary spasm observed during angiography in six patients with variant angina.
Methods
Study patients. From 1982 From to 1987 patients with the syndrome of Prinzmetal's variant angina underwent cardiac catheterization in our institution. Of these, six (five men, one woman; mean age 50 ? 7 years) developed coronary spasm spontaneously during cardiac catheterization and are the *Performed in the noninvasive laboratory. E = effort: ECG = electrocardiogram; F = female; LAD = left anterior descending coronary artery: LCx = left circumflex coronary artery: LMS = left main stem; M = male: R = rest; RCA = right coronary artery; ST = ST segment; J = depression: T = elevation. subject of this report. All six patients had a history typical of variant angina, with angina1 episodes at rest, usually at night and in the early morning hours, but with preserved exercise capacity. Angina1 episodes were associated with transient ST segment elevation (five patients) or depression (one patient). documented by ambulatory electrocardiographic (ECG) monitoring. Since the onset of the syndrome of variant angina, these patients had had periods of spontaneous waxing and waning of the disease. Although at admission all patients were in an active phase of their variant angina, with one to eight angina1 episodes (mean 2.8 episodes/patient) in the week preceding admission, angina1 attacks were usually short-lasting and resolved spontaneously within 3 min or were promptly relieved by sublingual nitrates in all cases. The clinical and angiographic characteristics of the patients are summarized in Table 1 .
Ergonovine provocative testing. Each patient underwent provocative testing in the noninvasive laboratory with incremental doses of ergonovine and 12 lead ECG monitoring, using a protocol described in detail elsewhere (3). During intravenous ergonovine administration, all patients had their usual angina1 pain, which was associated with marked ST segment elevation in five patients and ST segment depression in one patient, thus reproducing findings during spontaneous angina1 episodes (Table I) . Ergonovine-induced myocardial ischemia was completely reversed within 60 s by intravenous isosorbide dinitrate.
Cardiac catheterization. Every patient gave written informed consent for coronary arteriography and administration of ergonovine during cardiac catheterization. The study protocol was approved by the Hammersmith Hospital Ethics Committee.
Use of antianginal medications was discontinued at least 48 h before cardiac catheterization, with the exception of sublingual nitrates, which were administered as needed. Patients were studied in the fasting state, received no premeditation and had not smoked or taken sublingual nitrates in the 6 h preceding coronary arteriography. The Judkins technique was used in all patients. Baseline diagnostic (control) coronary angiograms were obtained in Patients 1, 2, 3, 4 and 5. In these five patients chest pain developed spontaneously 1 to 3 min after baseline coronary angiography and was associated with ischemic ST segment changes in four (Patients 1 through 4). Angiography of the appropriate coronary artery was immediately performed and demonstrated nonocclusive focal coronary spasm in all cases. The coronary artery to receive an injection during spontaneous chest pain was selected on the basis of either ECG changes observed during monitoring at angiography (Patients 1 through 4) or the result of the ergonovine test previously performed in the noninvasive laboratory (Patient 5). In Patient 6, ischemic ST segment changes in the anterior leads and chest pain developed spontaneously before diagnostic coronary angiography was performed. Left coronary arteriography revealed focal coronary spasm of both the left anterior descending coronary artery and left main stem. Coronary angiography was repeated without therapy in this patient within 1 week of the previous study to obtain further information for clinical management and this second coronary arteriogram was used as control. Patients were not kept in the catheterization laboratory until spontaneous coronary spasm developed. As described earlier, spasm developed by chance 1 to 3 min after completion of baseline coronary angiograms in Patients 1 to 5 and before baseline angiography in Patient 6.
Ergonovine testing during cardiac catheterization. In four patients (Patients 1, 3, 4 and 5), coronary spasm resolved spontaneously within 60 s. These four patients then underwent provocative testing with incremental doses of intravenous ergonovine (3) during cardiac catheterization, which provoked focal spasm in all four. Ergonovine-induced spasm was promptly reversed by intracoronary isosorbide dinitrate (1 to 3 mg) in all four cases. In Patient 2, in whom spasm did not resolve spontaneously within 1 min, and in Patient 6, who had spasm of both the left anterior descending artery and left main stem, intracoronary isosorbide dinitrate (2 mg) was immediately given, with prompt resolution of spasm in both cases. These two patients were not administered ergonovine during cardiac catheterization. Angiograms were also obtained during ergonovine testing in Patients 1, 3, 4 Coronary diameter measurements. During coronary angiography, the rotation and skew angles, height and magnification factors of the X-ray image intensifier were not altered so that comparable arteriograms were obtained before, during and after spontaneous spasm or provocations. Our technique to measure coronary artery diameters has been reported in detail previously (2). Briefly, coronary luminal diameters were measured by an automated edge contour detection computerized system (Coronary Angiography Analysis System [CAAS], Pie Data Medical). The size of the stem of the Judkins coronary catheter was used for calibration to absolute measurement units in millimeters and correction was made for radiographic pincushion distortion. Coronary arteriograms were analyzed by two independent observers and blindly reanalyzed at a remote time for reproducibility of the method. No significant difference in the variances between analyses was found.
Coronary segments considered for measurement are schematically shown in Figure 1 . In the spastic vessel, the spastic segment as well as one proximal and one distal nonspastic segment were analyzed. Proximal and distal coronary segments of the nonspastic circumflex artery were also analyzed when spasm developed in the left anterior descending coronary artery. Narrowed segments that did not change in diameter after administration of intracoronary nitrates at the end of the study were considered "fixed" stenoses. Data analysis. Minimal luminal diameter of spastic and nonspastic coronary segments at baseline angiography (in the absence of chest pain or ECG changes), during spontaneous spasm and ergonovine-induced spasm and after administration of nitrates was measured in millimeters. Results are expressed as mean values + 1 SD of the absolute values of the minimal luminal diameter at the site of spastic and nonspastic segments. Changes in coronary caliber of spastic and nonspastic segments are expressed as percent change relative to control values. Paired and unpaired t tests were used, as appropriate, to analyze changes in luminal diameter. A p value < 0.05 was considered statistically significant.
Results
Baseline angiography. In no cases were severe (>50% luminal diameter reduction) coronary atheromatous obstructions observed during baseline angiography, although patients had organic coronary stenoses ranging from 11% to 42% diameter reduction (Tables 1 and 2 ). During control arteriography, the luminal diameter of segments that developed spasm was 2.19 +-0.49 mm, whereas luminal diameters of proximal and distal nonspastic segments were 3.39 ? 0.74 and 2.79 + 0.43 mm, respectively (Tables 3 and 4) .
Spontaneous coronary spasm. Angina and ischemic ST segment changes that occurred in association with coronary spasm during cardiac catheterization developed when no catheter manipulations or contrast injections were being carried out. Spontaneous nonocclusive focal spasm developed at the site of mild atheromatous coronary stenoses (range 11% to 42% diameter reduction) in all cases. However, fixed stenoses of a similar severity were also present in coronary segments that did not develop spasm (Table 1) . Spontaneous spasm occurred in the left anterior descending coronary artery in Patients 1 and 5, in the right coronary artery in Patients 2, 3 and 4 and simultaneously in both the left anterior descending artery and left main stem (60% luminal diameter reduction) in Patient 6 (Table 2) .
Spontaneous coronary spasm was associated with angina and transient ischemic ST segment changes in five patients and with only minor chest discomfort in 1 patient (Patient 5) ( Table 2 ). Myocardial ischemia subsided spontaneously within 60 s in four patients and resolved immediately after intracoronary isosorbide dinitrate (2 mg) in two. Angina during spontaneous spasm was associated with ST segment elevation in Patients 2, 3 and 6 and with ST segment depression in Patients 1 and 4. Patient 5 had mild chest disconfort and no ischemic ST segment changes (Table 2) .
Ergonovine-induced spasm. Ergonovine, which was administered to four patients during cardiac catheterization, provoked occlusive focal spasm at the same site as spontaneous coronary spasm in all four cases (Table 2) . Ergonovine-induced spasm was associated with angina and ST segment elevation in all four patients (Table 2) ; prompt resolution of ergonovine-induced spasm followed the intracoronary administration of isosorbide dinitrate in all cases.
Behavior of spastic segments. During spontaneous spasm mean coronary diameter of spastic segments was reduced by 64.2 f 18.6% from control (from 2.19 f 0.49 to 0.73 k 0.28 mm: p < 0.001) ( Table 3 , Fig. 2 and 3) . The degree of luminal diameter reduction observed at the site of spastic segments during spontaneous spasm significantly exceeded that predicted by the geometric theory: 64.2 f 18.6% versus 41 t 12%, respectively (p < 0.05).
During ergonovine-induced spasm, mean diameter of spastic segments was reduced by 91.5 '_ 17% (from 1.99 mm [mean control value in the four patients who received ergonovinel to 0.14 mm; p < 0.001). The extent of luminal reduction was significantly greater (p = 0.01) after administration of ergonovine compared with that during spontaneous spasm.
Behavior of nonspastic segments. Eighteen nonspastic segments were analyzed: two in each spastic vessel and another six (three proximal and three distal) in the circumflex arteries of the three patients in whom spasm of the left anterior descending coronary artery developed (Fig. 1) . Fig. 2 and 3 ). The degree of coronary constriction observed during spontaneous spasm was not significantly different in nonspastic segments of the spastic vessel compared with segments located in unrelated arteries: 15.3 ? 8% versus 12.3 ? 9% reduction in caliber, respectively (p = 0.46). Moreover, the extent of constriction of proximal and distal nonspastic segments was also similar (p = 0.74) ( Table 4 , Fig. 3 ). Changes in caliber observed during spontaneous coronary spasm in the proximal segments of nonspastic coronary arteries were also similar irrespective of the presence or absence of organic stenoses: during spontaneous spasm, the nonspastic coronary segments without detectable stenoses showed a 13 * 7% reduction in luminal caliber and the nonspastic segments with obstructions of 12% to 40% showed a 14.7 ? 9% reduction (p = 0.76). During ergonovine-induced spasm, the extent of luminal diameter reduction of proximal nonspastic segments from control was not significantly different from that observed during spontaneous spasm: 17.7 + 9.8% versus 13.2 ? 7.5%; p = 0.52 (Table 4 , Fig. 2 and 3) . Luminal diameter of unrelated arteries was reduced by 17.75 ? 9% during ergonovine-induced spasm.
Effects of intracoronary nitrates on spastic and nonspastic segments. Intracoronary isosorbide dinitrate was administered to all patients to relieve either spontaneous (two patients) or ergonovine-induced spasm (four patients). After intracoronary isosorbide dinitrate, the coronary diameter of spastic segments increased by 20.7 t 23.9% compared with control (from 2.19 t 0.49 to 2.60 ? 0.55 mm) (Table 3 , Fig.  2 and 3 ). Coronary diameter of proximal and distal nonspastic segments increased by 18 + 13.5% and 16.5 ? 12%, respectively (Table 4 , Fig. 3 ). Compared with control, differences observed between the coronary dilation of spastic and nonspastic segments after nitrate administration were not statistically significant (Fig. 3) . All patients completed the study without occurrence of any untoward cardiac events.
Discussion
Mild, generalized vasoconstriction in the presence of severe focal spasm in variant angina. In this study we have documented, using computerized coronary arteriography, that in addition to the focal and exaggerated vasoconstriction that develops in the spastic segments during spontaneous spasm, a mild and diffuse vasoconstriction occurs in the remaining segments of the spastic artery and in the nonspastic coronary arteries in patients with Prinzmetal's variant angina. Ergonovine-provoked focal spasm at the same site as spontaneous spasm but the extent of luminal narrowing induced by this agent was greater, probably reflecting that different stimuli may elicit different degrees of response from the hyperreactive segment. Nonspastic segments during both spontaneous spasm and ergonovine-induced spasm, however, showed similar degrees of vasoconstriction. Our findings provide the first objective demonstration that spontaneous coronary spasm in patients with variant angina results from a local exaggerated constrictor response to a generalized stimulus, which produces only mild constriction in both the remaining segments of the spastic vessel and in the nonspastic coronary arteries. The findings in our study are in agreement with the observations of Curry et al. (4) , who noted mild, generalized epicardial coronary diameter reduction in some nonspastic segments during both spontaneous and ergonovine-induced spasm in patients with variant angina. These investigators, however, did not quantify the degree of coronary constriction that developed in spastic and nonspastic segments.
Mechanism of coronary spasm in variant angina. Although the nature of the generalized vasoconstrictor stimulus is unknown, the demonstration of its effect on hyperreactive coronary segments and nonspastic arteries is important for the understanding of the mechanisms of coronary spasm in variant angina. indeed, for spontaneous coronary spasm to develop, both a hyperreactive coronary segment and a generalized constrictor stimulus affecting all coronary vessels appear to be necessary. We (3) and others (5-10) have shown that, in patients with variant angina, a large variety of different stimuli, and not a specific stimulus only, can produce coronary constriction to a degree similar to that produced in this study, thus indicating that a local nonspecific coronary hyperreactivity to different constrictors is of paramount importance in the genesis of spasm in variant angina. This may explain why theories that propose specific receptor-agonist interactions involving parasympathetic (6), alpha-adrenergic (1 l-13), histaminergic (14) and serotonergic (IS) mechanisms or thromboxane A,-prostacyclin imbalance ( 16) as the cause of coronary spasm could not be confirmed (15, (17) (18) (19) (20) (21) (22) (23) (24) . It also explains why, although specific antagonists fail to prevent spasm (15, (17) (18) (19) (20) (21) (22) (23) (24) , drugs that nonspecifically reduce the constrictor response of the coronary smooth muscle, such as nitrates and calcium antagonists, are effective for treatment of variant angina (25-28).
Because constrictor stimuli are often present during ordinary daily activities, changes of the 'threshold" for spasm at the site of the hyperreactive segments are likely to play a major role in determining the frequency and severity of ischemic episodes in patients with variant angina. We previously suggested that a variable susceptibility to spasm is present in variant angina because the dose of ergonovine required to provoke spasm in the same patient at different times is extremely variable (29). A variable susceptibility to spasm, within individuals, is also consistent with the frequent observation of active phases alternating with quiescent periods or long-lasting remissions (30, 31) . During a quiescent period or during treatment with calcium antagonists, spasm can sometimes be triggered by potent stimuli such as ergonovine; in most patients, however, the ergonovine test also may become negative transiently or persistently (30) (31) (32) (33) .
This study also demonstrates that focal coronary spasm does not result from the amplification of physiologic vasoconstriction at sites of subintimal plaques as proposed by MacAlpin ("geometric theory") (34) . Although focal spasm occurred consistently in association with atheromatous coronary narrowings, in our patients during spontaneous coronary spasm and as shown by Freedman et al. (35) during ergonovine challenge, the degree of vasoconstriction observed at the spastic segments far exceeded that predicted by the geometric theory, confirming the presence of a local coronary hyperreactivity. This is consistent with our findings during provoked coronary spasm (2,3) and also with recent observations of recurrence of spasm at the same arterial site over prolonged periods (36) .
Local coronary factors contributing to segmental spasm. The nature of the local coronary alteration that makes a particular coronary segment chronically hyperreactive to stimuli that cause only mild constriction in the other coronary arteries is not known. Certainly the syndrome of variant angina cannot be explained simply by the presence of an atheromatous plaque. Plaque rupture or fissuring is unlikely to be the cause of spontaneous spasm in the chronic forms of variant angina because this disease often remains relatively stable for months (30, 37) , as in the case of the six patients described in this study. Endothelial dysfunction caused only by a raised plaque is also an unlikely cause of local hyperreactivity because raised plaques were found to cover as much as 20% to 30% of the surface of epicardial coronary arteries of normal individuals who died in accidents (38) . Furthermore, a local deficit of endotheliumderived relaxing factor (39) probably does not play a role in the genesis of variant angina; in experimental animals endothelial denudation alone was found to be insufficient to trigger coronary spasm (40). Increased numbers of specific receptors in certain segments of the coronary arteries also seems unlikely, because the spastic segments are hyperreactive to a large number of agonists (3). A postjunctional supersensitivity (41) of local arterial smooth muscle appears as a more attractive hypothesis.
The finding in our patients that the dilator response to intracoronary nitrates was similar in spastic and nonspastic coronary segments is compatible with an abnormality confined to the constrictor response. The contrasting conclusions reached by Hill et al. (42) , who observed that in patients with variant angina coronary segments involved in coronary spasm exhibited an exaggerated response to nitro-glycerin, may be explained by an increased basal tone of the spastic segments in their patients.
Conclusions. Spontaneous focal coronary spasm in patients with variant angina results from the interaction between a local coronary hyperreactivity, probably involving the smooth muscle locally, and the presence of a generalized stimulus that affects all coronary arteries, provoking complete vessel occlusion only at the site of the local hyperreactivity and only mild constriction in nonspastic arteries. Animal models (40,43) might provide insight into the basic mechanisms potentially responsible for the local coronary hyperreactivity in variant angina.
Although focal coronary spasm as documented in this study is by far the most common clinical presentation of spasm in variant angina, the occasional observation of severe diffuse constriction involving all epicardial coronary arteries (44,45) may suggest that the interaction between the local hyperreactivity and constrictor stimuli may vary from patient to patient.
